MEK Inhibitor PD-0325901 Trial in Adolescents and Adults With NF1

Clinical trial NCT02096471 · COMPLETED

Trial details

NCT number: NCT02096471
Sponsor: University of Alabama at Birmingham
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Neurofibromatosis Type 1 and Growing or Symptomatic, Inoperable PN

Start date: 2014-06-01
Primary completion: 2017-08-09
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.